If immediate-release and extended-release formulations of buprenorphine are similarly efficacious to treat opioid use disorder, is one superior?
The researchers’ objective was to compare the patient satisfaction of adult outpatients with opioid dependence who were administered buprenorphine subcutaneously by depot vs those given the drug sublingually.
In a 1:1:1 ratio, patients were randomly assigned to receive a drug disposal kit and fact sheet, fact sheet alone, or no additional items when filling their opioid prescription.
The objective of this study was to describe differences between patients with chronic noncancer pain who could stop using chronic opioid analgesic therapy and those who exhibited refractory COAT reliance.
Most PPAs in prescribers’ practices focused on rules and consequences of noncompliance instead of on a shared treatment plan.
The authors propose evaluating which aspects of previous policy and practices for OUD should resume and which aspects of current policy and practice exemptions should continue.
The number of individuals filling buprenorphine prescriptions for OUD has plateaued but not decreased during the COVID-19 pandemic.
Walmart is being sued by the US Justice Department for its alleged role in the nation’s opioid crisis.
Researchers assessed whether patients with osteoarthritis and NSAID allergies have higher odds of developing opioid use disorder, and identified next steps to be considered for this patient population.
Adolescent sleep deficiency as an increased future risk for prescription opioid misuse was examined in a large nationally, representative database designed to track health behaviors and outcomes from adolescence to early adulthood.
